agingbiomarkers.com
June 2014 | Aging Diagnostics
http://www.agingbiomarkers.com/2014_06_01_archive.html
Should we Treat Aging as a Disease? Academic, pharmaceutical, healthcare policy and pension fund perspectives. Thursday, June 26, 2014 By DNAmite. Are you an expert in biomedical sciences, medical doctor, economist, data scientist, actuary, pensions fund manager? Would you like to influence research, healthcare and retirement policy and help governments, companies and individuals prepare for the rapidly changing future? Academic, pharmaceutical, healthcare policy and pension fund perspectives". The key o...
agingbiomarkers.com
Should we Treat Aging as a Disease? Academic, pharmaceutical, healthcare policy and pension fund perspectives | Aging Diagnostics
http://www.agingbiomarkers.com/2014/06/should-we-treat-aging-as-disease.html
Should we Treat Aging as a Disease? Academic, pharmaceutical, healthcare policy and pension fund perspectives. Thursday, June 26, 2014 By DNAmite. Are you an expert in biomedical sciences, medical doctor, economist, data scientist, actuary, pensions fund manager? Would you like to influence research, healthcare and retirement policy and help governments, companies and individuals prepare for the rapidly changing future? Academic, pharmaceutical, healthcare policy and pension fund perspectives". The key o...
funduma.org
Science PR-Russia ~ UMA FOUNDATION
http://www.funduma.org/p/science-pr-russia.html
В этом гаджете обнаружена ошибка. What is the Science PR? And how to make the publication of the news? 1 What is scientific press secretary and why this profession? 2 Resources for scientific PR. 3 Popularization of scientific articles. All of these questions, told us Alex Zhavoronkov CEO. InSilico Medicine, Inc. Head of the Laboratory. Center for Pediatric Hematology, Oncology and Immunology. And a specialist PR in Russia and abroad. At the end of the lecture was a competition for the best press release.
funduma.org
InSilico Medicine announces collaboration -- Canada Cancer and Aging Research Laboratories ~ UMA FOUNDATION
http://www.funduma.org/2014/10/insilico-medicine-announces.html
В этом гаджете обнаружена ошибка. Суббота, 25 октября 2014 г. InSilico Medicine announces collaboration - Canada Cancer and Aging Research Laboratories. InSilico Medicine, Inc. InSilico Medicine announces collaboration - Canada Cancer and Aging Research Laboratories. Insilico Medicine to fund CCARL's pilot research study in personalized medicine and aging research. This is the logo for the Canada Cancer and Aging Research Laboratories. Click here for more information. To my knowledge CCARL is the first c...
funduma.org
октября 2014 ~ UMA FOUNDATION
http://www.funduma.org/2014_10_01_archive.html
В этом гаджете обнаружена ошибка. Drug Discovery International - promote your work to Big Pharma. BRMC: Theoretical physicists and biologists tap into investment analysis for regenerative medicine. FREE DRUG DISCOVERY CONFERENCE IN THE HEART OF EUROPE. New in silico approaches to evaluating the efficacy of and repurposing drugs for aging and age-related diseases. Суббота, 25 октября 2014 г. InSilico Medicine announces collaboration - Canada Cancer and Aging Research Laboratories. InSilico Medicine, Inc.
funduma.org
International PhystechBio Conference-2014 ~ UMA FOUNDATION
http://www.funduma.org/2014/06/international-phystechbio-conference.html
В этом гаджете обнаружена ошибка. Понедельник, 23 июня 2014 г. International PhystechBio Conference-2014 at MIPT Gathers World Leaders in the Life Sciences. Leading representatives of science and industry from around the world gathered in the town of Dolgoprudny near Moscow for the Fourth International PhystechBio Conference, held by the Life Sciences Center at the Moscow Institute of Physics and Technology (MIPT) and Northern Biopharmaceutical Cluster. Nobel Prize winners Michael Levitt. PUBLIC RELEASE ...
funduma.org
июня 2015 ~ UMA FOUNDATION
http://www.funduma.org/2015_06_01_archive.html
В этом гаджете обнаружена ошибка. Drug Discovery International - promote your work to Big Pharma. BRMC: Theoretical physicists and biologists tap into investment analysis for regenerative medicine. FREE DRUG DISCOVERY CONFERENCE IN THE HEART OF EUROPE. New in silico approaches to evaluating the efficacy of and repurposing drugs for aging and age-related diseases. Понедельник, 22 июня 2015 г. IBM, Skolkovo Foundation and FORAC will jointly develop targeted medicine platform. Within the agreement, IBM and ...
funduma.org
апреля 2015 ~ UMA FOUNDATION
http://www.funduma.org/2015_04_01_archive.html
В этом гаджете обнаружена ошибка. Drug Discovery International - promote your work to Big Pharma. BRMC: Theoretical physicists and biologists tap into investment analysis for regenerative medicine. FREE DRUG DISCOVERY CONFERENCE IN THE HEART OF EUROPE. New in silico approaches to evaluating the efficacy of and repurposing drugs for aging and age-related diseases. Среда, 8 апреля 2015 г. Thursday, April 16, 2015. 7 am Eastern, 4 am Pacific, 12 Noon UK, 1 pm Central Europe. Rune Linding, Ph.D. If you inter...
funduma.org
IBM, Skolkovo Foundation and FORAC will jointly develop targeted medicine platform ~ UMA FOUNDATION
http://www.funduma.org/2015/06/ibm-skolkovo-foundation-and-forac-will.html
В этом гаджете обнаружена ошибка. Понедельник, 22 июня 2015 г. IBM, Skolkovo Foundation and FORAC will jointly develop targeted medicine platform. Within the agreement, IBM and ‘First Oncology Research and Advisory Center’ plan to provide the know-how and methods for assisting clinicians in making treatment decisions with support from IBM Watson Health and FORAC’s OncoFinder solution. 171;The OncoFinder is a popular signalome-wide pathway analysis platform used for personalizedmedicine and drug repurposi...
SOCIAL ENGAGEMENT